These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10099073)

  • 21. The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.
    Batty KT; Davis TM; Ilett KF; Dusci LJ; Langton SR
    Br J Clin Pharmacol; 1995 Mar; 39(3):305-11. PubMed ID: 7619673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients.
    Lehnigk B; Rabe KF; Dent G; Herst RS; Carpentier PJ; Magnussen H
    Eur Respir J; 1998 Mar; 11(3):617-23. PubMed ID: 9596112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the addition of ciprofloxacin on theophylline pharmacokinetics in subjects inhibited by cimetidine.
    Davis RL; Quenzer RW; Kelly HW; Powell JR
    Ann Pharmacother; 1992 Jan; 26(1):11-3. PubMed ID: 1606331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of terbinafine on theophylline pharmacokinetics in healthy volunteers.
    Trépanier EF; Nafziger AN; Amsden GW
    Antimicrob Agents Chemother; 1998 Mar; 42(3):695-7. PubMed ID: 9517954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
    Gidal BE; Maganti R; Laurenza A; Yang H; Verbel DA; Schuck E; Ferry J
    Epilepsy Res; 2017 Aug; 134():41-48. PubMed ID: 28535410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ephedra water decoction and cough tablets containing ephedra and liquorice on CYP1A2 and the pharmacokinetics of theophylline in rats.
    Tang J; Zhou X; Ji H; Zhu D; Wu L
    Phytother Res; 2012 Mar; 26(3):470-4. PubMed ID: 21796703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel does not affect the pharmacokinetics of theophylline.
    Caplain H; Thebault JJ; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline.
    Stass H; Kubitza D
    Clin Pharmacokinet; 2001; 40 Suppl 1():63-70. PubMed ID: 11352444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL; Suri A
    Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.
    Bapiro TE; Sayi J; Hasler JA; Jande M; Rimoy G; Masselle A; Masimirembwa CM
    Eur J Clin Pharmacol; 2005 Nov; 61(10):755-61. PubMed ID: 16261361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
    Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
    J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
    Kim EJ; Suh OK; Lee MG
    Life Sci; 2003 Jan; 72(11):1231-45. PubMed ID: 12570924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline.
    Pan WJ; Goldwater DR; Zhang Y; Pilmer BL; Hunt RH
    Aliment Pharmacol Ther; 2000 Mar; 14(3):345-52. PubMed ID: 10735929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers.
    Boot JD; De Haas SL; Van Gerven JM; De Smet M; Leathem T; Wagner J; Denker A; Miller D; Van Doorn MB; Schoemaker RC; Cohen AF; Diamant Z
    Pulm Pharmacol Ther; 2008; 21(3):573-7. PubMed ID: 18321743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic interaction between lansoprazole and theophylline.
    Granneman GR; Karol MD; Locke CS; Cavanaugh JH
    Ther Drug Monit; 1995 Oct; 17(5):460-4. PubMed ID: 8585108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of theophylline clearance by rifampin and rifabutin in healthy male volunteers.
    Gillum JG; Sesler JM; Bruzzese VL; Israel DS; Polk RE
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1866-9. PubMed ID: 8843295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic changes of unbound theophylline are due to plasma protein binding displacement and CYP1A2 activity inhibition by baicalin in rats.
    Gao N; Fang Y; Qi B; Jia LJ; Jin H; Qiao HL
    J Ethnopharmacol; 2013 Nov; 150(2):477-84. PubMed ID: 24076258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor.
    Machinist JM; Mayer MD; Roberts EM; Surber BW; Rodrigues AD
    Drug Metab Dispos; 1998 Oct; 26(10):970-6. PubMed ID: 9763401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis.
    Mohamed MF; Camp HS; Jiang P; Padley RJ; Asatryan A; Othman AA
    Clin Pharmacokinet; 2016 Dec; 55(12):1547-1558. PubMed ID: 27272171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide.
    von Richter O; Lahu G; Huennemeyer A; Herzog R; Zech K; Hermann R
    Clin Pharmacokinet; 2007; 46(7):613-22. PubMed ID: 17596106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.